Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
20%
ALSO IN PJP
PJP
32
HOLDINGS
43%
ALSO IN XLV
SECTOR DRIFT (XLV minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.1% | 5.2% | 5.2% |
|
ABBVIE INC | 7.8% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 10.8% | 5.0% | 5.0% |
|
MERCK & CO. INC. | 5.5% | 4.8% | 4.8% |
|
AMGEN INC | 3.5% | 5.1% | 3.5% |
XLV Overweight Relative to PJP
|
ELI LILLY & CO | 10.9% |
|
UNITEDHEALTH GROUP INC | 6.5% |
|
JOHNSON & JOHNSON | 5.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBVIE INC | 2.7% |
|
CVS CAREMARK CORP | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
DANAHER CORP | 2.1% |
|
INTUITIVE SURGICAL INC | 2.0% |
|
STRYKER CORP | 1.9% |
XLV Underweight Relative to PJP
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.6% |
|
TRAVERE THERAPEUTICS, INC. | -3.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -3.4% |
|
LIGAND PHARMACEUTICALS-CL B | -3.3% |
|
OCULAR THERAPEUTIX INC | -3.2% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -3.2% |
|
TARSUS PHARMACEUTICALS, INC. | -2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.8% |
|
INNOVIVA, INC. | -2.8% |